ModivCare (MODV)
(Delayed Data from NSDQ)
$23.84 USD
+0.28 (1.19%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $23.87 +0.03 (0.13%) 5:06 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
ModivCare (MODV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$36.00 | $43.00 | $26.00 | 52.80% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for ModivCare comes to $36.00. The forecasts range from a low of $26.00 to a high of $43.00. The average price target represents an increase of 52.8% from the last closing price of $23.56.
Analyst Price Targets (3 )
Broker Rating
ModivCare currently has an average brokerage recommendation (ABR) of 2.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.50 a month ago based on four recommendations.
Of the five recommendations deriving the current ABR, one is Strong Buy, representing 20% of all recommendations. A month ago, Strong Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 3 | 3 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.60 | 2.60 | 2.50 | 2.50 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/2/2024 | Lake Street Capital Markets | Brooks G O'Neil | Not Available | Hold |
2/26/2024 | Barrington Research | Michael J Petusky | Strong Buy | Hold |
11/1/2023 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.60 |
ABR (Last week) | 2.60 |
# of Recs in ABR | 5 |
Average Target Price | $36.00 |
LT Growth Rate | 8.80% |
Industry | Medical Services |
Industry Rank by ABR | 81 of 252 |
Current Quarter EPS Est: | 0.21 |